BDAL’s Q1 New Bookings Rise by 25 Percent
Bruker Daltonics said last week that its new order bookings for life-science systems grew by 25 percent during the first quarter of 2002, compared with the same quarter of 2001. “We see real excitement and increasing demand for our Ultraflex TOF/TOF system,” Frank Laukien, Bruker Daltonics’ CEO, said in a statement. “Our shipments and installations for the Ultraflex are ramping up smoothly.”
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
